Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgan Roupret

Showing results (111-120 of 273) with videos related to

Pageof 28
Sort By:
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Alternating Cystoscopy with Bladder EpiCheck<sup>®</sup> in the Surveillance of Low-Grade Intermediate-Risk NMIBC: A Cost Comparison ModelYair Lotan, Georgios Gakis, Matteo Manfredi, et al.
Asian Journal of Andrology|February 10, 2021
Metabolic syndrome, levels of androgens, and changes of erectile dysfunction and quality of life impairment 1 year after radical prostatectomyYann Neuzillet, Mathieu Rouanne, Jean-François Dreyfus, et al.
La Revue Du Praticien|June 23, 2021
[Robots set up in the operating theater]Jacques Belghiti, Ugo Pinar, Morgan Roupret, et al.
Asian Journal of Andrology|March 25, 2021
Relationship of preoperative androgen levels and metabolic syndrome with quality of life and erectile function in patients who are to undergo radical prostatectomyYann Neuzillet, Jean-François Dreyfus, Jean-Pierre Raynaud, et al.
World Journal of Urology|October 5, 2022
Adherence to guideline recommendations in the management of upper tract urothelial carcinoma: an analysis of the CROES-UTUC registryJoyce Baard, Shahrokh F Shariat, Morgan Roupret, et al.
Clinical Genitourinary Cancer|August 18, 2016
Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical CystectomyMarco Moschini, Francesco Soria, Tobias Klatte, et al.
Prostate Cancer and Prostatic Diseases|October 21, 2024
Prostate cancer screening and management in patients candidate for endoscopic enucleation of the prostate: an international surveyAlessandro Uleri, Jean Nicolas Cornu, Benjamin Pradere, et al.
BJU International|November 5, 2013
Prognostic value of microRNA expression pattern in upper tract urothelial carcinomaLaura Izquierdo, Mercedes Ingelmo-Torres, Carmen Mallofré, et al.
Urology|September 15, 2015
The Diagnostic and Prognostic Performance of Urinary FGFR3 Mutation Analysis in Bladder Cancer Surveillance: A Prospective Multicenter StudyCamille Couffignal, François Desgrandchamps, Pierre Mongiat-Artus, et al.
Critical Reviews in Oncology/Hematology|August 5, 2019
Review of hypo-fractionated radiotherapy for localized muscle invasive bladder cancerFrédéric Amestoy, Guilhem Roubaud, Mikaël Antoine, et al.
Pageof 28

Showing results (111-120 of 273) with videos related to

Sort By:
Pageof 28
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Alternating Cystoscopy with Bladder EpiCheck<sup>®</sup> in the Surveillance of Low-Grade Intermediate-Risk NMIBC: A Cost Comparison ModelYair Lotan, Georgios Gakis, Matteo Manfredi, et al.
Asian Journal of Andrology|February 10, 2021
Metabolic syndrome, levels of androgens, and changes of erectile dysfunction and quality of life impairment 1 year after radical prostatectomyYann Neuzillet, Mathieu Rouanne, Jean-François Dreyfus, et al.
La Revue Du Praticien|June 23, 2021
[Robots set up in the operating theater]Jacques Belghiti, Ugo Pinar, Morgan Roupret, et al.
Asian Journal of Andrology|March 25, 2021
Relationship of preoperative androgen levels and metabolic syndrome with quality of life and erectile function in patients who are to undergo radical prostatectomyYann Neuzillet, Jean-François Dreyfus, Jean-Pierre Raynaud, et al.
World Journal of Urology|October 5, 2022
Adherence to guideline recommendations in the management of upper tract urothelial carcinoma: an analysis of the CROES-UTUC registryJoyce Baard, Shahrokh F Shariat, Morgan Roupret, et al.
Clinical Genitourinary Cancer|August 18, 2016
Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical CystectomyMarco Moschini, Francesco Soria, Tobias Klatte, et al.
Prostate Cancer and Prostatic Diseases|October 21, 2024
Prostate cancer screening and management in patients candidate for endoscopic enucleation of the prostate: an international surveyAlessandro Uleri, Jean Nicolas Cornu, Benjamin Pradere, et al.
BJU International|November 5, 2013
Prognostic value of microRNA expression pattern in upper tract urothelial carcinomaLaura Izquierdo, Mercedes Ingelmo-Torres, Carmen Mallofré, et al.
Urology|September 15, 2015
The Diagnostic and Prognostic Performance of Urinary FGFR3 Mutation Analysis in Bladder Cancer Surveillance: A Prospective Multicenter StudyCamille Couffignal, François Desgrandchamps, Pierre Mongiat-Artus, et al.
Critical Reviews in Oncology/Hematology|August 5, 2019
Review of hypo-fractionated radiotherapy for localized muscle invasive bladder cancerFrédéric Amestoy, Guilhem Roubaud, Mikaël Antoine, et al.
Pageof 28